When Regeneron announced a $500 million corporate venture capital fund last week, it was the first time in years that a storied large pharma had done so.
The company said it’s investing $100 million a year for five years.
Michael Aberman “Our goal is to…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
